- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
- 10-K Annual report
- 23.1 Consent of Independent Registered Public Accounting Firm, Bdo Seidman
- 23.2 Consent of Independent Registered Public Accounting Firm, Pricewaterhousecoopers
- 31.1 Certification of Robert E. Grant Pursuant to Rule 13A-14(A)
- 31.2 Certification of Richard L. Harrison Pursuant to Rule 13A-14(A)
- 32.1 Certification of Robert E. Grant Pursuant to 18 Usc Section 1350
- 32.2 Certification of Richard L. Harrison Pursuant to 18 Usc Section 1350
Exhibit 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. § 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Robert E. Grant, President and Chief Executive Officer of Biolase Technology, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(i) the Annual Report of the Company on Form 10-K for the period ended December 31, 2005 (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
By: | /s/ ROBERT E. GRANT | |
Robert E. Grant | ||
President and Chief Executive Officer | ||
March 16, 2006 |